English
中文简体
CPHI Exhibition Concludes Successfully | Cocrystal Technology Wins Gold Award for Natural Raw Materials with Hardcore Technology, Embarking on a New Journey of Angstrom-Level Innovation
The three-day CPHI & PMEC CHINA 2026 (World Pharmaceutical Ingredients China Exhibition) officially concluded on June 18 at the Shanghai New International Expo Center (Pudong). Cocrystal Technology showcased its self-developed Cocrysta® cocrystal product series at the exhibition, successfully completing its industry exhibition itinerary, achieving efficient connections and fruitful negotiations with upstream and downstream customers both domestically and internationally. The exhibition also brought significant industry honors.
This CPHI brought together global pharmaceutical, functional health ingredients, formulation R&D, health food, and other full-industry chain professionals, focusing on core industry pain points such as ingredient efficacy enhancement, solubility improvement, and bioavailability enhancement. It served as a core platform for industry exchange, business negotiation, and trend analysis. At this exhibition, Cocrystal Technology used it as an external window to directly face real market demands, showcase its self-developed core cocrystal technology, and provide implementable technical solutions for the application bottlenecks of poorly soluble active ingredients.
Concurrently with the exhibition, the CPHI China Pharma Awards 2026 for Natural Raw Materials were held. Relying on the outstanding technological innovation, absorption enhancement advantages, and market application potential of the Cocrysta® series cocrystal raw materials, Cocrystal Technology successfully won the Natural Ingredients Awards Gold Award. This honor represents the industry's authoritative recognition of the company's deep technological achievements and serves as strong evidence of Cocrystal Technology's competitiveness in the technology sector.
At the exhibition site, Cocrystal Technology displayed its full range of Cocrysta® raw materials, including eight core products: Reduced Coenzyme Q10, Curcumin, Hydroxytyrosol, Lutein, Urolithin A, Silybin, Rutin, and Vitamin E. All products have undergone systematic efficacy validation, supported by measured research data such as absorption kinetic curves and stability comparisons, intuitively demonstrating the advantages of cocrystal technology: breaking through traditional raw material issues like poor solubility, low in vivo absorption rate, and poor storage stability, significantly enhancing the bioavailability of active ingredients. They are also compatible with various dosage forms such as soft capsules, hard capsules, gummies, and oral liquids. The company can provide brand clients with diversified services including standardized raw material supply, customized development, and finished formulation solution development.
Throughout the three-day exhibition, the booth attracted a continuous stream of visitors, with numerous domestic and international procurement directors, formulation R&D engineers, and R&D directors from health food and special dietary brands stopping for exchanges. The Cocrystal team provided one-on-one explanations for different application scenarios, covering product efficacy validation conclusions, mass production capacity, quality control systems, and domestic and international patent layouts. They engaged in in-depth discussions on cooperation models such as new product launches, raw material substitution, and customized formulation development, accumulating a large number of precise intended clients and laying a solid foundation for subsequent market expansion and project implementation.
This appearance at CPHI was an important opportunity for Cocrystal Technology to deepen its presence in the high-absorption raw material track and demonstrate its technological strength. As the exhibition concludes, research and collaboration continue unabated. In the future, Cocrystal Technology will continue to iterate the Cocrysta® cocrystal product system, strengthen its mass production and customized R&D capabilities, and focus on upgrading and innovating poorly soluble ingredients. At the same time, it looks forward to joining hands with more industry partners, relying on Angstrom-level cocrystal innovative solutions, to promote the high-quality development of the big health industry and collectively explore new market spaces for highly active ingredients.
Address: Zhejiang | Jiaxing
Official Website: www.cocrystaltech.com
Email: [email protected]
Phone: 0573-84583582
Scan the QR code to follow us and get more cutting-edge information and professional exchanges.
